Leather, Helen <br/><br/>
Economic effects of aspergillosis management in high-risk patients.  [electronic resource] 

 -  Managed care interface  Apr 2005 
 - 46-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-5645 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amphotericin B--economics<br/>Antifungal Agents--economics<br/>Aspergillosis--drug therapy<br/>Cost-Benefit Analysis<br/>Hospitalization--economics<br/>Humans<br/>Insurance, Health, Reimbursement<br/>Pyrimidines--economics<br/>Triazoles--economics<br/>United States<br/>Voriconazole